Hemab Therapeutics Hldgs Ownership & Insider Activity

Hemab Therapeutics Hldgs (COAG) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.1% of shares outstanding. Institutional investors hold 21.6%. Over the past 90 days, insiders made 1 purchase worth $1.7M.

Shares Outstanding

46.712M

Insider Shares Owned

35.948K

Insider % Owned

0.1%

Institutional Shares Held

10.081M

Institutional % Held

21.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$1.7M total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$1.7M

Hemab Therapeutics Hldgs Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Jun 15, 2026	RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, Peter Kolchinsky, Rajeev Shah	10% OWNER	BUY	67.669K	$24.97	$1.7M
May 19, 2026	RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, Peter Kolchinsky, Rajeev Shah	10% OWNER	BUY	4.798K	$24.96	$120K
May 12, 2026	RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, Peter Kolchinsky, Rajeev Shah	10% OWNER	BUY	6.387K	$24.90	$159K
May 7, 2026	RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, Peter Kolchinsky, Rajeev Shah	10% OWNER	BUY	51.258K	$24.75	$1.3M
May 4, 2026	RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, RA Capital Nexus Fund II LP, RA Capital Nexus Fund IV LP, Peter Kolchinsky, Rajeev Shah	DIRECTOR	BUY	7.679M	$18.39	$52.2M